Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...

Shares of Gilead Sciences Inc. rose 3.07% to $106.34 Monday, on what proved to be an all-around great trading session for the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

As the Trump administration stares down diversity programs, this big Peninsula employer is highlighting its efforts.

Elisabeth Moss and Max Minghella tell TheWrap if the commander should be given grace for revealing Mayday's plans The post ...

It seems unlikely that The Handmaid’s Tale is going to end with June Osborne ( Elisabeth Moss) and Nick Blaine (Max Minghella ...

As the final season of The Handmaid's Tale approaches, fans are on tenterhooks to find out if June Osborne (portrayed by ...

ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways in which the ...

Nick and June are reunited in The Handmaid’s Tale Season 6 Episode 6, ‘Surprise’, but does it end well? Here’s your full recap.

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...